Zdrowie i gospodarka · 13/09/2012

FDA Announces Fee Rates for Priority Review Voucher in FY 2013

The Food and Drug Administration (FDA) has set the fee rate for using a priority review voucher for fiscal year 2013, which is based on the average cost incurred by FDA in reviewing human drug applications in the previous year.